Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/3084| Title: | POLATUZUMAB, BENDAMUSTINE and RITUXIMAB EFFICACY IN RELAPSED/REFRACTORY TRIAL-INELIGIBLE LARGE B CELL LYMPHOMA PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY | Authors: | Shaw, B.;Chung, E.;Wellard, C.;Yoo, E.;Bennett, R.;Birks, C.;Johnston, A.;Cheah, C.;Hamad, N.;Simpson, J.;Barraclough, A.;Ku, M.;Viiala, N.;Ratnasingam, S.;Armytage, Tasman ;Cochrane, T.;Chong, G.;Lee, D.;Manos, K.;Keane, C.;Wallwork, S.;Opat, S.;Hawkes, E. | Affliation: | Central Coast Local Health District Gosford Hospital |
Issue Date: | 1-Jun-2023 | Department: | Pathology | Abstract: | Hematological Oncology. Conference: 17th International Conference on Malignant Lymphoma. Lugano Switzerland. 41(Supplement 2) (pp 718-719), 2023. | URI: | https://hdl.handle.net/1/3084 | Publicaton type: | Conference Abstract |
| Appears in Collections: | Oncology / Cancer |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.